ABCB5 and acute kidney injury: Taken together, the modulation of cisplatin-induced pathways by ABCB5+ MSC grafts implies that this cell population continues to hold promise for further investigations aimed at the prevention or improvement of cisplatin-induced AKI, following additional adjustment of dosing or timing strategies and additional relevant parameters.